Show simple item record

dc.contributor.authorEkmekci, H.
dc.contributor.authorTugcu, Deniz
dc.contributor.authorAydogan, G.
dc.contributor.authorUnuvar, A.
dc.contributor.authorDevecioglu, O.
dc.contributor.authorOzturk, G.
dc.contributor.authorEkmekci, O. B.
dc.contributor.authorAnak, S.
dc.contributor.authorAkcay, A.
dc.date.accessioned2021-03-05T16:41:22Z
dc.date.available2021-03-05T16:41:22Z
dc.date.issued2016
dc.identifier.citationTugcu D., Devecioglu O., Unuvar A., Ekmekci H., Ekmekci O. B. , Anak S., Ozturk G., Akcay A., Aydogan G., "Plasma Levels of Plasminogen Activator Inhibitor Type 1 and Vitronectin in Children With Cancer", CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, cilt.22, ss.28-33, 2016
dc.identifier.issn1076-0296
dc.identifier.otherav_c1d97098-7b3c-490e-93c6-af36255d09e5
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/128664
dc.identifier.urihttps://doi.org/10.1177/1076029614531450
dc.description.abstractBackground: The plasminogen activator system controls intravascular fibrin deposition; besides, it also participates in a wide variety of physiologic and pathologic processes, including cancer.
dc.language.isoeng
dc.subjectHematoloji
dc.subjectTıp
dc.subjectİç Hastalıkları
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectPERİFERAL VASKÜLER HASTALIĞI
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectHEMATOLOJİ
dc.titlePlasma Levels of Plasminogen Activator Inhibitor Type 1 and Vitronectin in Children With Cancer
dc.typeMakale
dc.relation.journalCLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume22
dc.identifier.issue1
dc.identifier.startpage28
dc.identifier.endpage33
dc.contributor.firstauthorID228373


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record